{"id":4868,"date":"2020-11-09T09:39:36","date_gmt":"2020-11-09T09:39:36","guid":{"rendered":"http:\/\/venturamedicaltechnologies.com\/?p=4868"},"modified":"2026-01-26T11:32:48","modified_gmt":"2026-01-26T11:32:48","slug":"3d-biopsy-tomosynthesis-ventura-acc1o","status":"publish","type":"post","link":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/","title":{"rendered":"El proyecto de investigaci\u00f3n 3D-Biopsia por tomos\u00edntesis, en el que participa Baldomero Ventura SL, presenta sus resultados a ACC1\u00d3"},"content":{"rendered":"<h3 style=\"text-align: justify;\"><strong><em>La Agencia para la Competitividad de la Empresa (ACCI\u00d3) acredit\u00f3 en 2016 las tecnolog\u00edas aplicadas a la salud como Comunidad RIS3CAT.<\/em><\/strong><\/h3>\n<p style=\"text-align: justify;\">Se impulsaron 13 Comunidades RIS3CAT con un presupuesto total de 53 millones de euros, ayudas gestionadas por <a href=\"https:\/\/www.accio.gencat.cat\/ca\/inici\/\">ACCI\u00d3<\/a>, parte del cual procede del Fondo Europeo de Desarrollo Regional (FEDER).<\/p>\n<p style=\"text-align: justify;\">Todos ellos movilizan una inversi\u00f3n en investigaci\u00f3n e innovaci\u00f3n de m\u00e1s de 140 millones de euros. Uno de ellos se enmarca en el \u00e1mbito sectorial de las industrias de la salud y las ciencias de la vida.<\/p>\n<p style=\"text-align: justify;\">Dentro de esta comunidad se seleccion\u00f3 el proyecto de investigaci\u00f3n, desarrollo e innovaci\u00f3n Biopsia 3D por tomos\u00edntesis. Baldomero Ventura participa en este proyecto junto con otras instituciones, como IDNEO Tecnolog\u00edas (FICOSA), el Instituto de F\u00edsica de Altas Energ\u00edas (IFAE), el Centro de Diagn\u00f3stico UDIAT \u2013 Fundaci\u00f3n Parc Taul\u00ed Sabadell, y el Centro Nacional de Microelectr\u00f3nica (CNM) \u2013 Centro Superior de Investigaci\u00f3n Cient\u00edfica (CSIC). El objetivo del proyecto era desarrollar productos y tecnolog\u00edas innovadoras en el campo de los dispositivos de biopsia que mejoraran la precisi\u00f3n del diagn\u00f3stico, al tiempo que permitieran optimizar la planificaci\u00f3n de los tratamientos a seguir por el paciente, redundando as\u00ed en una mayor eficacia y sostenibilidad del hospital. recursos destinados a terapias y una mayor tasa de recuperaci\u00f3n post-tratamiento del paciente, por tanto, una mejor calidad de vida de la poblaci\u00f3n general.<\/p>\n<p style=\"text-align: justify;\">El resultado ha sido la consecuci\u00f3n de un prototipo de instrumento cient\u00edfico de inter\u00e9s para los miembros de la comunidad y por los diferentes agentes del sector sanitario, que permite probar y validar una nueva tecnolog\u00eda enfocada a mejorar la resoluci\u00f3n de la visi\u00f3n de los profesionales sanitarios en el diagn\u00f3stico de patolog\u00edas mamarias en dec\u00fabito prono. El Prototipo desarrollado podr\u00e1 convertirse en un dispositivo m\u00e9dico tras su fase de industrializaci\u00f3n y validaci\u00f3n regulatoria. Adem\u00e1s, se podr\u00e1n implementar futuros modelos de negocio para su explotaci\u00f3n.<\/p>\n<p style=\"text-align: justify;\">RIS3CAT es una estrategia de investigaci\u00f3n e innovaci\u00f3n impulsada por la Comisi\u00f3n Europea y aprobada por la Generalitat de Catalu\u00f1a que identifica siete \u00e1reas sectoriales l\u00edderes en las que Catalu\u00f1a tiene una ventaja competitiva, como son las industrias de la salud y las ciencias de la vida. Es una apuesta por la I+D y la innovaci\u00f3n para fomentar el crecimiento econ\u00f3mico, as\u00ed como generar nueva actividad econ\u00f3mica y nuevos puestos de trabajo. Las comunidades RIS3CAT son agrupaciones de empresas que impulsan planes de acci\u00f3n de I+D+i en los \u00e1mbitos sectoriales identificados.<\/p>\n<p style=\"text-align: justify;\"><u>Un proyecto de I+D+i<\/u><\/p>\n<p style=\"text-align: justify;\">Desarrollar productos y tecnolog\u00edas innovadores en el campo de los dispositivos de biopsia era el objetivo del proyecto Biopsia 3D por tomos\u00edntesis. Esta iniciativa pretende conseguir una planificaci\u00f3n del tratamiento m\u00e1s \u00f3ptima y uno de sus objetivos ha sido conseguir una mayor tasa de recuperaci\u00f3n postratamiento del paciente.<\/p>","protected":false},"excerpt":{"rendered":"<p>The Agency for the Competitiveness of the Enterprise (ACCI\u00d3) accredited [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4874,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4868","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3 - Ventura Medical Technologies<\/title>\n<meta name=\"description\" content=\"The Agency for the Competitiveness of the Enterprise (ACCI\u00d3) accredited in 2016 the technologies applied to health as a RIS3CAT Community.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3 - Ventura Medical Technologies\" \/>\n<meta property=\"og:description\" content=\"The Agency for the Competitiveness of the Enterprise (ACCI\u00d3) accredited in 2016 the technologies applied to health as a RIS3CAT Community.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/\" \/>\n<meta property=\"og:site_name\" content=\"Ventura Medical Technologies\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-09T09:39:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-26T11:32:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/venturamedicaltechnologies.com\/wp-content\/uploads\/2020\/11\/proyecto-biopsia-3d.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/#\\\/schema\\\/person\\\/8d91b3587f008efa467ca05a90e3f6c5\"},\"headline\":\"The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3\",\"datePublished\":\"2020-11-09T09:39:36+00:00\",\"dateModified\":\"2026-01-26T11:32:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/\"},\"wordCount\":450,\"image\":{\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/proyecto-biopsia-3d.jpg\",\"articleSection\":[\"Sin categorizar\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/\",\"url\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/\",\"name\":\"The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3 - Ventura Medical Technologies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/proyecto-biopsia-3d.jpg\",\"datePublished\":\"2020-11-09T09:39:36+00:00\",\"dateModified\":\"2026-01-26T11:32:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/#\\\/schema\\\/person\\\/8d91b3587f008efa467ca05a90e3f6c5\"},\"description\":\"The Agency for the Competitiveness of the Enterprise (ACCI\u00d3) accredited in 2016 the technologies applied to health as a RIS3CAT Community.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/#primaryimage\",\"url\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/proyecto-biopsia-3d.jpg\",\"contentUrl\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/proyecto-biopsia-3d.jpg\",\"width\":900,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/3d-biopsy-tomosynthesis-ventura-acc1o\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/\",\"name\":\"Ventura Medical Technologies\",\"description\":\"Desarrollo de productos m\u00e9dicos\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/#\\\/schema\\\/person\\\/8d91b3587f008efa467ca05a90e3f6c5\",\"name\":\"admin\",\"sameAs\":[\"https:\\\/\\\/venturamedicaltechnologies.com\"],\"url\":\"https:\\\/\\\/venturamedicaltechnologies.com\\\/es\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3 - Ventura Medical Technologies","description":"La Agencia para la Competitividad de la Empresa (ACCI\u00d3) acredit\u00f3 en 2016 las tecnolog\u00edas aplicadas a la salud como Comunidad RIS3CAT.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/","og_locale":"es_ES","og_type":"article","og_title":"The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3 - Ventura Medical Technologies","og_description":"The Agency for the Competitiveness of the Enterprise (ACCI\u00d3) accredited in 2016 the technologies applied to health as a RIS3CAT Community.","og_url":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/","og_site_name":"Ventura Medical Technologies","article_published_time":"2020-11-09T09:39:36+00:00","article_modified_time":"2026-01-26T11:32:48+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/venturamedicaltechnologies.com\/wp-content\/uploads\/2020\/11\/proyecto-biopsia-3d.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/#article","isPartOf":{"@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/"},"author":{"name":"admin","@id":"https:\/\/venturamedicaltechnologies.com\/es\/#\/schema\/person\/8d91b3587f008efa467ca05a90e3f6c5"},"headline":"The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3","datePublished":"2020-11-09T09:39:36+00:00","dateModified":"2026-01-26T11:32:48+00:00","mainEntityOfPage":{"@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/"},"wordCount":450,"image":{"@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/#primaryimage"},"thumbnailUrl":"https:\/\/venturamedicaltechnologies.com\/wp-content\/uploads\/2020\/11\/proyecto-biopsia-3d.jpg","articleSection":["Sin categorizar"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/","url":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/","name":"The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3 - Ventura Medical Technologies","isPartOf":{"@id":"https:\/\/venturamedicaltechnologies.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/#primaryimage"},"image":{"@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/#primaryimage"},"thumbnailUrl":"https:\/\/venturamedicaltechnologies.com\/wp-content\/uploads\/2020\/11\/proyecto-biopsia-3d.jpg","datePublished":"2020-11-09T09:39:36+00:00","dateModified":"2026-01-26T11:32:48+00:00","author":{"@id":"https:\/\/venturamedicaltechnologies.com\/es\/#\/schema\/person\/8d91b3587f008efa467ca05a90e3f6c5"},"description":"La Agencia para la Competitividad de la Empresa (ACCI\u00d3) acredit\u00f3 en 2016 las tecnolog\u00edas aplicadas a la salud como Comunidad RIS3CAT.","breadcrumb":{"@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/#primaryimage","url":"https:\/\/venturamedicaltechnologies.com\/wp-content\/uploads\/2020\/11\/proyecto-biopsia-3d.jpg","contentUrl":"https:\/\/venturamedicaltechnologies.com\/wp-content\/uploads\/2020\/11\/proyecto-biopsia-3d.jpg","width":900,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/venturamedicaltechnologies.com\/es\/3d-biopsy-tomosynthesis-ventura-acc1o\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/venturamedicaltechnologies.com\/"},{"@type":"ListItem","position":2,"name":"The research project 3D-Biopsy by tomosynthesis, in which Baldomero Ventura SL participates, presents its results to ACC1\u00d3"}]},{"@type":"WebSite","@id":"https:\/\/venturamedicaltechnologies.com\/es\/#website","url":"https:\/\/venturamedicaltechnologies.com\/es\/","name":"Ventura Medical Technologies","description":"Desarrollo de productos m\u00e9dicos","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/venturamedicaltechnologies.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/venturamedicaltechnologies.com\/es\/#\/schema\/person\/8d91b3587f008efa467ca05a90e3f6c5","name":"administraci\u00f3n","sameAs":["https:\/\/venturamedicaltechnologies.com"],"url":"https:\/\/venturamedicaltechnologies.com\/es\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/posts\/4868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/comments?post=4868"}],"version-history":[{"count":2,"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/posts\/4868\/revisions"}],"predecessor-version":[{"id":13725,"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/posts\/4868\/revisions\/13725"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/media\/4874"}],"wp:attachment":[{"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/media?parent=4868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/categories?post=4868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/venturamedicaltechnologies.com\/es\/wp-json\/wp\/v2\/tags?post=4868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}